AIM
SCPH

Alambic Investment Management’s scPharmaceuticals SCPH Stock Holding History

Alambic Investment Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-38,623
Closed -$284K – 143
2020
Q2 		$284K Sell
38,623
-2,900
-7% -$25.5K 0.71% 53
2020
Q1 		$307K Sell
41,523
-9,500
-19% -$68.9K 0.74% 54
2019
Q4 		$289K Sell
51,023
-4,791
-9% -$24.5K 0.24% 167
2019
Q3 		$328K Sell
55,814
-4,033
-7% -$22.7K 0.25% 155
2019
Q2 		$191K Buy
+59,847
New +$196K 0.12% 240

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Alambic Investment Management's SCPH Position: Q3 2020 in Review

Alambic Investment Management sold out of scPharmaceuticals (SCPH) in Q3 2020, closing a stake of 38,623 shares — an estimated $284K sold.

Alambic Investment Management first reported a position in SCPH in Q2 2019 and held it in 5 quarters. The position peaked at $328K in Q3 2019. 51 funds tracked by Wall St. Rank hold SCPH as of Q3 2020.

  • Alambic Investment Management reported no remaining scPharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Alambic Investment Management sold 38,623 scPharmaceuticals shares in Q3 2020, an estimated $284K.
  • Alambic Investment Management first reported a position in scPharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Alambic Investment Management's scPharmaceuticals position peaked at $328K in Q3 2019.
  • 51 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2020.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.